The Swiss NanoAnalytics platform within the Adolphe Merkle Institute's BioNanomaterials group offers high quality services for the analysis of nanoparticles. This includes characterization of the physicochemical properties of nanomaterials, isolation and analysis of the occurrence of particles in food products and cosmetics, testing the stability and size of nanomedicines in biological fluids (e.g. blood serum), and testing material composites used in electronics or construction materials.
Furthermore, in connection with the development of Covid-19 vaccines or therapeutic nanocarriers (e.g. liposomal or polymer capsules), we offer characterization services, support the characterization of such vaccines or nanocarriers and provide relevant information at an early stage of development.